Imprimis Dexamethasone-Moxifloxacin Injection Recall: Faulty Crimps Risk Contamination
Imprimis recalls 13 vials of Dexamethasone-Moxifloxacin injection due to faulty crimps causing potential contamination. Affected lots: 20JUN010 (expiring 5/12/21).
Lower-risk recall
Lack of assurance of sterility: 13 vials were discovered to have faulty crimps.
Contact the company
What happened, in plain English
Imprimis recalled 13 vials of Dexamethasone-Moxifloxacin injection because faulty crimps in the vials could lead to contamination. This affects patients receiving this medication, especially those with compromised immune systems. Read more at govinfonow.com/recall/36583-imprimis-dexamethasone-moxifloxacin-injection-recall-faulty-crimps-risk-contamination.
Source Summary by GovInfoNow · govinfonow.com/recall/36583-imprimis-dexamethasone-moxifloxacin-injection-recall-faulty-crimps-risk-contamination · Updated October 4, 2026 · FDA enforcement record: FDA #D-0177-2021
Cite this page
“Imprimis Dexamethasone-Moxifloxacin Injection Recall: Faulty Crimps Risk Contamination.” GovInfoNow, updated October 4, 2026. https://govinfonow.com/recall/36583-imprimis-dexamethasone-moxifloxacin-injection-recall-faulty-crimps-risk-contamination. Based on FDA recall #D-0177-2021 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0177-2021%22&limit=1).
Why it’s dangerous
Faulty crimps in the vials could allow contamination during use. This is a sterility issue that might lead to infections if the medication is not properly sterile.
Who’s affected
Patients using this injection for medical treatment are affected. Those with weakened immune systems face higher risk due to potential contamination.
How to tell if you have this one
Check for vials labeled 'Dexamethasone - Moxifloxacin PF Injection (1/5) mg/mL, Imprimis Rx Volume: 1mL/vial' with lot number 20JUN010 (expiring 5/12/21).
- Brand
Imprimis- Category
Drug
What to do — step by step
Check Vial Label
Look for the lot number 20JUN010 on the vial label to confirm if it's affected.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “U.S.A. Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 2.7 years after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0177-2021 (December 17, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0177-2021 to see it in context.
- Plain-language summary written by qwen3:4b on October 4, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.